Overview
This actively managed equity fund invests in Swiss companies.
The fund focuses on companies with strong fundamentals that are expected to be able to pay sustainable dividends.
The fund offers a diversified portfolio across capitalization levels and sectors with a maximum single stock concentration of 10% - providing better diversification than standard Swiss equity indices.
UBS High Dividend Funds have typical equity risk characteristics and are designed for risk tolerant investors who are willing to bear the risk and volatility of equity investments.
Benefits
Easy access to Swiss stocks.
The focus on high quality stocks aims to exclude companies that do not pay sustainable dividends.
Investors can profit from a portfolio that seeks optimal diversification with regards to single stock weights and sector allocations.
The fund draws on the knowledge of proven investment specialists based in Zurich.
Risks
Features
| Product category |
Equity Europe |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
January 9, 2014
|
| Currency of account |
CHF
|
| Close of financial year |
October 31
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.65% p.a.
|
| Flat fee |
0.64% p.a.
|
| Management fee |
0.51% p.a.
|
| Total expense ratio (TER) |
0.64% p.a.
|
| Minimum investment |
-
|
| Reference Index / Benchmark |
SPI® (TR)
|
| Cut-Off Time |
15:00h(CET)
|
| Securities no. |
20555209
|
| ISIN |
CH0205552091
|
| Bloomberg Ticker |
UBSHIA1 SW
|
| Telekurs Id |
EFSHDA1
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 3.11 | 4.49 | 4.07 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 18.45 | 19.87 | 35.78 |
| 3Y | |||
| 5Y | 43.17 | 72.36 | 67.52 |
| ø p.a.5Y | 7.44 | 11.50 | 10.87 |
Current data
| Net asset value | 23.04.2026 | CHF 212.13 |
| High - last 12 months | 27.02.2026 | CHF 214.23 |
| Low - last 12 months | 23.06.2025 | CHF 184.37 |
| Last distribution | 16.01.2026 | CHF 1.00 |
| Assets of the unit class in mn | 23.04.2026 | CHF 66.41 |
| Total product assets in mn | 23.04.2026 | CHF 1,186.12 |
| Indicative current dividend yield | 31.03.2026 | 2.87% |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 11.72% | 12.29% |
| Sharpe Ratio | 31.03.2026 | 0.83 | 0.55 |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By the 10 largest equity positions (in %, as of March 31, 2026)
|
|
|
| Nestle SA | 9.80 |
| Novartis AG | 9.71 |
| Roche Holding AG | 8.98 |
| Zurich Insurance Group AG | 8.61 |
| UBS Group AG | 8.18 |
| ABB Ltd | 7.96 |
| Swiss Re AG | 5.46 |
| Cie Financiere Richemont SA | 4.18 |
| Givaudan SA | 3.88 |
| Lonza Group AG | 3.83 |
Fees
Distributions
|
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Tax domicile CH gross amount
|
Tax domicile CH net amount
|
Tax domicile not CH gross amount
|
Tax domicile not CH net amount
|
Remarks
|
|||||||||||||||||||||
| 08.05.2025 | 12.05.2025 | 23 | CHF | 3.84 | 2.50 | 3.84 | 2.50 | Income | 14.01.2026 | 16.01.2026 | 24 | CHF | 0.36 | 0.23 | 0.36 | 0.23 | Income | 14.01.2026 | 16.01.2026 | 25 | CHF | 0.64 | 0.64 | 0.64 | 0.64 | Capital gain or income from direct property |
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|